https://www.linkedin.com/posts/john-simon-8ab8b194_xenonmri-revolutionizingpulmonarymedicine-activity-7295847663835430944-y2OX?utm_source=share&utm_medium=member_android&rcm=ACoAADdraCMBGzU5aJKAr453wDwlS2etY-tqE0cThis could and should reap big dividends and exposure ongoing at their 250 plus sites stateside. One initially, baby steps, it's a great collaboration on top of medical and university institutes we are currently growing...Forecasts? 10-15 sites by end of 2025, currently on 7.- 2 long hanging deals soon.- simonmed expansion ongoing - Taiwan - China??- the world Exciting times at rock bottom price. |
Think it should really consolidate around the 1.6 area till next newslow |
Me thinks they're running out of stock. Quite a % tightly held here and it always has moved fast. |
Sweet, when the masses see what's going on here and a Chinese collab emerges this is going to the moon. Even if we start filling simonmed locations this could see a return to the £1 mark if this impetus continues |
The share price is consolidating at a higher level than the past few months. It will rise further in the coming weeks. I expect good news flow. |
Next leg up, next week and with news. Next week could be the consolidate above 2p stage... I'm sure everyone will appreciate that! |
Coming in today. Glad I had a ickle top up |
https://www.linkedin.com/posts/polarean-inc-_innovation-xenonmri-pulmonaryimaging-activity-7295884156440379393-Qw9t?utm_source=share&utm_medium=member_android |
Had another 569k |
Is this an upgrade model? Are we going to get the upgrade sale in the bag soon? |
https://www.linkedin.com/posts/alan-huang-phd_xenonmri-xenonmri-sbrt-ugcPost-7295434253515845632-Hxqt?utm_source=share&utm_medium=member_androidIowa |
https://www.linkedin.com/posts/daniel-e-booker_xenonmri-activity-7295485914712014848-9PnP?utm_source=share&utm_medium=member_androidPresenting the wares |
Seller having finished would be great, any news and it won't matter, as we need shut of amati they destroyed this share price for the last 2 years. |
I think the main reason is the seller has finished so no longer dragging the share price down . News however is due on several fronts too which should give this a nice kick and get us past 2p finally |
The Chinese distribution partner will make this a massive spike. And we have another Chinese patent pending. All the sales directors now covering every region of the states will be dropping sales soon, As we know and stated by the company, Duke and Iowa upgrade to clinical will be confirmed soon. |
Recent news and technicals and short term prospect of further news puts it on a favourable footing... we don't want short term trading at the mo. Steady momentum towards 2p. News about a variety of positive avenues could drop anytime. The U.S perspective always makes the pm. a potential of news as the bod wakes up stateside and fda time.Am I right that anytime February is good chance of the fda expansion approval news? That's the time i had in my head... at best. |
Something significantly positive is happening in the background. There will be an RNS soon. |
Big jump, new break out to next level... trade levels yesterday were definitely higher mark than presented. Finally, nice and steady as she goes. |
Offering well over mid for quantity dummy sell. Should be seeing movement soon |
https://www.linkedin.com/posts/polarean-inc-_mri-pulmonaryimaging-lunghealth-activity-7294739548708712451-d3po?utm_source=share&utm_medium=member_androidSouth east region sales director... another. This could go ballistic should they all pull in sales. |
Presume struggling for sellers in qty they want at mo re step up unwarranted on trades and no delayed |
there will be a multi millionaires party should it do so! If it's gets a fashionable buzz again on good solid news, who knows. But the journey would likely be interrupted by a T/O |
9mda about to cross the 100mdaChart so positiveNewsflow incredibly positiveSentiment changing rapidly here More to come soon, next news should see us firmly back over 2p. |
Contacted their pr team about the glaring typo on there. |